Kim Forest Enterprise CoTPE:6645 -0.96%61 Days Payable is 47.04 as of Dec. 2025, which is 33% below its 10-year median of 70.66. GuruFocus rates TPE:6645 with a GF Score™ of 61/100 and a GF Value™ of NT$24.64 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Kim Forest Enterprise Co ranks worse than 53.16% on this metric.
The historical rank and industry rank for Kim Forest Enterprise Co's Days Payable or its related term are showing as below:
TPE:6645'
s Days Payable Range Over the Past 10 Years
Min: 57.81 Med: 70.66 Max: 93.11
Current: 62.18
During the past 13 years, Kim Forest Enterprise Co's highest Days Payable was 93.11. The lowest was 57.81. And the median was 70.66.
TPE:6645's Days Payable is ranked worse than 53.16% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.385
vs TPE:6645: 62.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6645 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Kim Forest Enterprise Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kim Forest Enterprise Co Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kim Forest Enterprise Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Kim Forest Enterprise Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kim Forest Enterprise Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kim Forest Enterprise Co (TPE:6645) has a Days Payable of 47.04 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kim Forest Enterprise Co and its competitors. This is 33% below median its historical median of 70.66. Over the past decade, Kim Forest Enterprise Co's Days Payable has ranged from 57.81 to 93.11. According to the industry distribution chart, Kim Forest Enterprise Co ranks #101 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 53.2%.
Is Kim Forest Enterprise Co's Days Payable too high?
Kim Forest Enterprise Co's current Days Payable of 47.04 is 33% below median its 10-year median of 70.66. Over the past 10 years, this metric has ranged from a low of 57.81 to a high of 93.11. The Medical Diagnostics & Research industry median Days Payable is 65.39. Kim Forest Enterprise Co's value of 47.04 is 28.1% below this industry median. Based on the distribution chart, Kim Forest Enterprise Co ranks #101 out of 190 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Kim Forest Enterprise Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kim Forest Enterprise Co's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kim Forest Enterprise Co ranks #101 out of 190 companies for Days Payable. This places Kim Forest Enterprise Co in the lower half of its industry. The industry median Days Payable is 65.39. Kim Forest Enterprise Co's value of 47.04 is 28.1% below this benchmark. Historically, Kim Forest Enterprise Co's own Days Payable has ranged from 57.81 to 93.11 over the past decade. While the company's 10-year median is 70.66 vs. the industry median of 65.39, Kim Forest Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.39, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kim Forest Enterprise Co's current Days Payable of 47.04 is 28.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kim Forest Enterprise Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kim Forest Enterprise Co's current Days Payable is 47.04, which is 33% below median its own 10-year median of 70.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kim Forest Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Kim Forest Enterprise Co (TPE:6645) is currently considered Possible Value Trap. The stock's GF Value™ is NT$24.64, compared to a current price of NT$15.55 — trading 36.9% below its estimated fair value. The current Days Payable is 47.04, which is 33% below median its 10-year median of 70.66 and 28.1% below the Medical Diagnostics & Research industry median of 65.39. Kim Forest Enterprise Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kim Forest Enterprise Co (TPE:6645), the current Days Payable is 47.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kim Forest Enterprise Co (TPE:6645) Overvalued in 2026?
Based on GuruFocus' analysis, Kim Forest Enterprise Co stock appears to be undervalued.
The current stock price of NT$15.55 is trading 36.9% below its estimated GF Value™ of NT$24.64.
GuruFocus considers Kim Forest Enterprise Co to be Possible Value Trap.
Key valuation signals for TPE:6645:
Days Payable: 47.04 (33% below median its 10-year median of 70.66)
GF Value™: NT$24.64 vs. price of NT$15.55 (36.9% below fair value)
Industry Position: 28.1% below the Medical Diagnostics & Research median (#101 of 190)
No single metric tells the full story. See the TPE:6645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kim Forest Enterprise Co Ltd is engaged in providing clinical medical information, genetic testing services, and biological information. It manufactures medical equipment and also produces drug products. The company's equipment includes Desktop microcentrifuge, Desktop large capacity centrifuge, Filter-type absorption spectrometer, Multifunctional spectrometer, and many more. Its reportable segments are Biomedical products which generates key revenue, and the Precision medicine segment. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States of America.
61GF Score
Get the complete analysis for TPE:6645
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6645 has been successfully added to your 
